N@N

LTD, PNC, OMCL, USB, SGEN, WABC, Expected to Trade Lower After Bearish Insider Trading

October 28, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. LIMITED BRANDS, INC. (NYSE:LTD), PNC FINANCIAL SERVICES GROUP INCORPORATED (NYSE:PNC), OMNICELL INCORPORATED (NASDAQ:OMCL), U.S. BANCORP (NYSE:USB), SEATTLE GENETICS, INC. (NASDAQ:SGEN), WESTAMERICA BANCORP (NASDAQ:WABC) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     LTD        LIMITED BRANDS, INC.                Turney, Sharen Jester               O           193,762        77                -12.2%                 7         
     PNC        PNC FINANCIAL SERVICES GROUP INCORPORATED     Hannon, Michael J                   O           5,000          76                -8.6%                  11        
     OMCL       OMNICELL INCORPORATED               Lipps, Randall A                    CEO         11,728         78                -3.9%                  69        
     USB        U.S. BANCORP                        Hartnack, Richard C                 O           30,193         81                -10.3%                 3         
     SGEN       SEATTLE GENETICS, INC.              Dobmeier, Eric L                    CO          20,461         92                -13.1%                 11        
     WABC       WESTAMERICA BANCORP                 Finger, Jennifer J                  OT          15,848         81                -5.6%                  10        

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

LIMITED BRANDS, INC. (NYSE:LTD) - Limited Brands, Inc. operates as a retailer of womens intimate and other apparel, beauty and personal care products, and accessories in the United States and Canada. It offers lingerie, fragrances, cosmetics, shower gels, lotions, antibacterial soaps, candles, accessories, and spa products under Victorias Secret, Pink, La Senza, Bath & Body Works, C. O. Bigelow, The White Barn Candle Company, and Henri Bendel brands. The company sells its merchandise through its specialty retail stores, Web sites, and catalogues. As of March 15, 2010, it operated 2,970 specialty stores. The company was formerly known as The Limited, Inc. and changed its name to Limited Brands, Inc. in May 2002. Limited Brands, Inc. was founded in 1963 and is based in Columbus, Ohio.

PNC FINANCIAL SERVICES GROUP INCORPORATED (NYSE:PNC) - The PNC Financial Services Group, Inc. operates as a diversified financial services company. It offers retail banking, corporate and institutional banking, asset management, and residential mortgage banking services. Its retail banking products and services comprise deposit, lending, brokerage, trust, investment management, and cash management services. The company also offers corporate and institutional banking products and services, including lending products, such as secured and unsecured loans, letters of credit and equipment leases; treasury management services comprising cash and investment management, receivables management, disbursement, funds transfer, information reporting, and global trade services; and capital markets-related services, such as foreign exchange, derivatives, loan syndications, mergers and acquisitions advisory and related services for mid-sized corporations, government, not-for-profit entities, and large corporations, as well as offers commercial loan servicing, real estate advisory, and technology solutions for the commercial real estate finance industry. In addition, it manages assets on behalf of institutional and individual investors through equity, fixed income, alternative and cash management separate accounts, and funds, as well as offers market risk management, financial markets advisory, and enterprise investment system services worldwide. Further, the company offers distressed assets, such as commercial residential development loans, cross-border leases, consumer brokered home equity loans, retail and non-prime mortgages, and residential construction loans. It primarily operates in Pennsylvania, Ohio, New Jersey, Michigan, Maryland, Illinois, Indiana, Kentucky, Florida, Missouri, Virginia, Delaware, Washington, D.C., and Wisconsin. As of December 31, 2009, the company operated 2,512 retail banking branches and 6,473 ATMs. The PNC Financial Services Group was founded in 1922 and is headquartered in Pittsburgh, Pennsylvania.

OMNICELL INCORPORATED (NASDAQ:OMCL) - Omnicell, Inc. develops, markets, sells, and supports medication and supply dispensing systems to the healthcare industry primarily in the United States and Canada. Its products include OmniRx dispensing system that automates the management and dispensing of medications at the point of use; Mobile Carts, a mobile wireless computer and dispensing system that allows medication control to be taken to the bedside and provides a platform for other hospital information systems; and SinglePointe, a software product that is used to control medications on a patient-specific basis. The company also offers OmniLinkRx, a software product that automates communication between nurses and the pharmacy; WorkflowRx, an automated storage, retrieval, and repackaging solution for the central pharmacy; SecureVault, a controlled substance barcode inventory management system; SafetyMed, a mobile nursing workflow automation and barcode medication administration system; and Anesthesia Workstation, a mobile system for the management of anesthesia supplies and medications. Its medication and surgical supply products include Omnicell Supply Solution that dispenses and tracks medical and surgical supplies at the point of use; Supply/Rx Combination Solution, which is designed to manage medications and supplies in one versatile cabinet or group of cabinets; Omnicell Tissue Center; OptiFlex SS for the perioperative areas; and OptiFlex CL for the cardiac catheterization lab and other procedure areas. In addition, Omnicell provides customer education and training, maintenance and support, post-installation, technical support, and onsite services; Omnicell Interface Software; and professional services. The company also sells its products through distributors in Asia, Australia, Europe, the Middle East, and South America. It was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was founded in 1992 and is headquartered in Mountain View, California.

U.S. BANCORP (NYSE:USB) - U.S. Bancorp, a financial bank holding company, provides various banking and financial services in the United States. It generates various deposit products, including checking accounts, savings accounts, money market savings, and time certificates of deposit accounts. The company originates a portfolio of loans comprising commercial loans and lease financing; commercial real estate; residential mortgage; and retail loans, including credit card, retail leasing, home equity and second mortgages, and other retail loans. It also offers wholesale lending, equipment finance, small-ticket leasing, depository, treasury management, capital markets, foreign exchange, and international trade services to middle market, large corporate, commercial real estate, and public sector clients. In addition, U.S. Bancorp provides telebanking, online banking, direct mail, and automated teller machine (ATM) services. The company, through other subsidiaries, provides trust, private banking, financial advisory, investment management, retail brokerage services, insurance, and custody and mutual fund services; and payment services, including consumer and business credit cards, stored-value cards, debit cards, corporate and purchasing card services, consumer lines of credit, ATM processing, and merchant processing. U.S. Bancorp primarily serves individuals, estates, foundations, business corporations, and charitable organizations. As of November 12, 2010, it operated 3,013 bank branches and 5,323 ATMs. U.S. Bancorp was formerly known as Firstar Corporation and changed its name on February 28, 2001. The company was founded in 1863 and is headquartered in Minneapolis, Minnesota.

SEATTLE GENETICS, INC. (NASDAQ:SGEN) - Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Its lead product, SGN-35 is in pivotal trial stage used for the treatment of patients with relapsed or refractory hodgkin lymphoma. The companys other product candidates in various stages of clinical trials include SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; dacetuzumab (SGN-40), a humanized anti-CD40 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc.; Daiichi Sankyo Co., Ltd.; Genentech, Inc.; GlaxoSmithKline LLC; Millennium; and PSMA Development Company LLC. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc.; and Genmab A/S. Seattle Genetics, Inc. was founded in 1997 and is headquartered in Bothell, Washington.

WESTAMERICA BANCORP (NASDAQ:WABC) - Westamerica Bancorporation operates as the holding company for Westamerica Bank that provides various banking services to individuals and corporate customers in northern and central California. Its deposit products include money market savings and checking accounts; non interest bearing demand account deposits; interest bearing transaction, savings, and time accounts; and certificates of deposit. The companys portfolio of loans includes commercial and residential real estate loans, commercial loans, and real estate construction loans. As of December 31, 2009, the company operated 97 offices in 22 counties in Northern and Central California, including 14 offices in Fresno county; 11 each in Marin and Sonoma counties; 7 in Merced, Napa, and Stanislaus counties; 5 ach in Lake, Contra Costa, and Solano counties; 4 in Kern county; 3 each in Alameda, Sacramento, and Tulare counties; 2 each in Mendocino, Nevada, Placer, and Tulare Counties; and 1 each in Merced, San Francisco, Tuolumne, Kings, Madera, Mariposa, and Yolo Counties. The company was formerly known as Independent Bankshares Corporation and changed its name to Westamerica Bancorporation in 1983. Westamerica Bancorporation was founded in 1972 and is headquartered in San Rafael, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net